March 28, 2008
Journals Resist a Drug Company's Subpoenas, Citing the Threat to Peer Review
Grandiose language has appeared in the pages of medical journals this month, as well as in federal court, about a looming threat to peer review.
The threat comes in the form of subpoenas from the pharmaceutical giant Pfizer requesting confidential peer reviews and editors' comments about two of Pfizer's arthritis drugs: Celebrex and Bextra. The latter is now off the market, and Pfizer is defending itself in court against plaintiffs who think they were injured as a result of
This is an article for subscribers only. You may access this article by purchasing a:
Digital or Print Subscription
Web Pass
Already have an account? Log In Now.
-
First Person
-
Notes From Academe
-
Commentary
